Q4 2020 · —
derived · Computed from the longer spans the company filed.
Revenue$0.00$0.00 derivedno prior Q4 2019 on file−100.0% vs Q3 2020
Net Income-$17.19M-$17.19M derivedno prior Q4 2019 on fileN/M vs Q3 2020
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$17,477,000—
Operating Cash Flowderived-$16,823,000—
Free Cash Flowderived-$62,094,000—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
no prior Q4 2019 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Instil Bio, Inc. · CIK 1789769 · Engraved from SEC EDGAR